搜索
Niagen Bioscience Inc
NAGE添加自选
3.665USD
-0.135-3.55%
交易中 （美东）报价延迟15分钟
291.21M总市值
15.69市盈率 TTM
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-3.55%
5天
-12.53%
1月
-21.86%
6月
-46.65%
今年开始到现在
-42.37%
1年
-63.71%
TradingKey Niagen Bioscience Inc股票评分
单位: USD 更新时间: 2026-05-14操作建议
Niagen Bioscience Inc当前公司基本面数据相对非常健康，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在生物技术与医疗研究行业排名69/382位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价12.60。中期看，股价处于下降通道。近一个月，市场表现非常差，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Niagen Bioscience Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Niagen Bioscience Inc亮点
亮点风险
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
业绩高增长
公司营业收入稳步增长，连续3年增长54.87%
估值合理
公司最新PE估值16.27，处于3年历史合理位
景顺投资公司持仓
明星投资者景顺投资公司持仓，最新持仓市值19.64K
活跃度降低
近期活跃度降低，过去20天平均换手率0.03
分析师目标
根据
5
位分析师
买入
评级
12.600
目标均价
+235.11%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Niagen Bioscience Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Niagen Bioscience Inc简介
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代码NAGE
公司Niagen Bioscience Inc
CEOFried (Robert N)
网址https://www.niagenbioscience.com/
相关品种
